Table 1 Summary characteristics of MS patients.
From: Seasonal variability of serum 25-hydroxyvitamin D on multiple sclerosis onset
Variable | Mean ± SD [range]/n (%) |
|---|---|
N | 40 |
+ Relapsing-remitting disease | 38 (95%) |
+ Primary progressive disease | 2 (5%) |
Female | 32 (80%) |
Age (years) | 36.5 ± 9.0 [18–53] |
Age at first symptom (years) | 33.8 ± 9.2 [18–53] |
Age at diagnosis (years) | 36.7 ± 9.1 [18–53] |
Disease duration (years) | 2.6 ± 3.5 [0–13] |
Disease duration, ≤ 1 year | 24 (60%) |
EDSS ≥ 2 | 14 (35%) |
OCB presence | 32 (82.1%) |
CSF IgG Index | 1.15 ± 0.76 [0.40–4.82] |
Serum 25(OH)D level (nmol/L) | 49.6 ± 19.4 [17.0–95.0] |
Serum 25(OH)D level (adj)* (nmol/L) | 47.8 ± 17.7 [4.4–77.6] |
